B7-1 and interleukin 12 synergistically induce effective antitumor immunity

Enhanced host rejection of tumor cells is the primary goal of cancer immunotherapy and, in many murine tumor models, has been accomplished by engineering cells to express B7 costimulatory molecules or creating an environment rich in certain cytokines. We examined the effect of tumor cell B7-1 expres...

Ausführliche Beschreibung